WASHINGTON, July 11, 2012 /PRNewswire-USNewswire/ -- The Consumer Healthcare Products Association (CHPA) today applauds U.S. Sens. Bob Casey (D–PA) and Lisa Murkowski (R-AK) for introducing legislation to help combat teen cough medicine abuse. The Preventing Abuse of Cough Treatments (PACT) Act of 2012 would prohibit the sale of over-the-counter (OTC) cough medicines containing dextromethorphan (DXM) to teens under the age of 18.
DXM is a safe and effective cough suppressant found in more than 100 cough and cold medicines. While millions of Americans rely on these medicines to relieve cough and cold symptoms, the 2011 National Institute on Drug Abuse's (NIDA's) Monitoring the Future survey found that approximately 5 percent of teens in grades 8-12 report abusing DXM-containing medicines by ingesting large amounts to get "high" – sometimes as much as 25 or more times the recommended dose.
"This legislation powerfully complements our ongoing educational initiatives to raise awareness about this troubling behavior," CHPA President and CEO Scott M. Melville said. "It will give parents an additional tool to prevent abuse, while ensuring access for the millions of adults and families who responsibly use products containing DXM to relieve cough symptoms. We are extremely pleased to see such strong leadership from Sens. Casey and Murkowski and encourage Congress to pass this legislation."
CHPA, the trade association representing the makers of OTC medicines and dietary supplements, has long supported national educational efforts to curb teen OTC cough medicine abuse through its StopMedicineAbuse.org education campaign, which includes collaborations with The Partnership at Drugfree.org, Community Anti-Drug Coalitions of America (CADCA), National Association of School Nurses (NASN), D.A.R.E. America, WebMD, and ot
|SOURCE Consumer Healthcare Products Association|
Copyright©2012 PR Newswire.
All rights reserved